...
首页> 外文期刊>Journal of Plant Protection Research >Application of new bioformulations of Pseudomonas aureofaciens for biocontrol of cotton seedling damping-off
【24h】

Application of new bioformulations of Pseudomonas aureofaciens for biocontrol of cotton seedling damping-off

机译:新的金黄色假单胞菌生物制剂在棉花苗期抑菌生防中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Pseudomonas aureofaciens (30-84) is a phenazine producing bacterium and reported as asuccessful biocontrol agent of some plant fungal pathogens. In the present study, the possibility of biological control of cotton damping-off caused by Rhizoctonia solani (AG-4) through phenazine production by the 30-84 strain, was investigated. In the search for the development of bioformulations of Pa (m) (PhzR ) and Pa (w) (PhzR') strains of 30-84, four new carriers including soybean meal (SM), cottonseed meal (CM), rice bran (RB), and talc powder (TAL) were selected. The efficacy of bacterial formulations in reducing disease incidence was evaluated in four intervals (15, 30, 45, and 60 days after sowing), and compared with each bacterial suspension efficacy under green-house conditions. The results revealed that organic carriers were more effective than talc powder. It was also found that all the bioformulations were more efficient than each bacterial suspension. The most effective in reducing disease incidencewas Pa (w) + RB. In contrast, Pa (m), Pa (m) + TAL, and Pa (m) + RB did not significantly suppress the disease in comparison with the infested control. Thus, phenazine production as a main biocontrol mechanism of P. aureofaciens (30-84) may be affectedby the kind of carriers used for the bioformula-tion development.
机译:金黄假单胞菌(30-84)是一种产生吩嗪的细菌,据报道可作为某些植物真菌病原体的成功生物防治剂。在本研究中,研究了通过30-84菌株产生的吩嗪对茄红枯萎病(AG-4)造成的棉花减振进行生物学控制的可能性。为了开发30-84的Pa(m)(PhzR)和Pa(w)(PhzR')菌株的生物制剂,开发了四种新载体,包括大豆粉(SM),棉籽粉(CM),米糠( RB)和滑石粉(TAL)。在四个时间间隔(播种后15、30、45和60天)评估了细菌制剂在减少疾病发生率方面的功效,并与温室条件下的每种细菌悬浮液功效进行了比较。结果表明,有机载体比滑石粉更有效。还发现所有生物制剂比每种细菌悬浮液更有效。降低疾病发生率最有效的方法是Pa(w)+ RB。相反,与感染对照相比,Pa(m),Pa(m)+ TAL和Pa(m)+ RB没有显着抑制该疾病。因此,吩嗪的生产作为金黄色葡萄球菌的主要生物防治机制(30-84)可能会受到用于生物制剂开发的载体种类的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号